Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cara Haymaker

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Biorxiv : the Preprint Server for Biology|January 7, 2025
Comparison of imaging-based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed, paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2021
Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver MetastasesPreeti Kanikarla Marie, Cara Haymaker, Edwin Roger Parra, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
A spatial atlas of chemoradiation therapy in pancreatic cancer identifies cellular and microenvironmental determinants of persister populationsVincent Bernard, Li-Ting Ku, Tianyu Wang, et al.
Cancer Discovery|September 14, 2018
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in MelanomaShelly Kalaora, Yochai Wolf, Tali Feferman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2026
First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL-2 in Patients with High-Grade Serous Ovarian CarcinomaHelen D Clark, Samira Aghlara-Fotovat, Jake Schladenhauffen, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
First-In-Human Trial of Encapsulated Cell-Based Protein Producers for Localized IL-2 in Patients with High-Grade Serous Ovarian CarcinomaHelen D Clark, Samira Aghlara-Fotovat, Jake Schladenhauffen, et al.
Oncoimmunology|July 7, 2017
Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot studyYong Qin, Mariana Petaccia de Macedo, Alexandre Reuben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2022
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic MelanomaCaitlin A Creasy, Yuzhong Jeff Meng, Marie-Andrée Forget, et al.
The Journal of Clinical Investigation|May 13, 2022
LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockadeAmber Hickman, Joost Koetsier, Trevin Kurtanich, et al.
Clinical and Translational Medicine|July 29, 2021
Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trialRaquel Laza-Briviesca, Alberto Cruz-Bermúdez, Ernest Nadal, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Biorxiv : the Preprint Server for Biology|January 7, 2025
Comparison of imaging-based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed, paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2021
Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver MetastasesPreeti Kanikarla Marie, Cara Haymaker, Edwin Roger Parra, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
A spatial atlas of chemoradiation therapy in pancreatic cancer identifies cellular and microenvironmental determinants of persister populationsVincent Bernard, Li-Ting Ku, Tianyu Wang, et al.
Cancer Discovery|September 14, 2018
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in MelanomaShelly Kalaora, Yochai Wolf, Tali Feferman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2026
First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL-2 in Patients with High-Grade Serous Ovarian CarcinomaHelen D Clark, Samira Aghlara-Fotovat, Jake Schladenhauffen, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
First-In-Human Trial of Encapsulated Cell-Based Protein Producers for Localized IL-2 in Patients with High-Grade Serous Ovarian CarcinomaHelen D Clark, Samira Aghlara-Fotovat, Jake Schladenhauffen, et al.
Oncoimmunology|July 7, 2017
Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot studyYong Qin, Mariana Petaccia de Macedo, Alexandre Reuben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2022
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic MelanomaCaitlin A Creasy, Yuzhong Jeff Meng, Marie-Andrée Forget, et al.
The Journal of Clinical Investigation|May 13, 2022
LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockadeAmber Hickman, Joost Koetsier, Trevin Kurtanich, et al.
Clinical and Translational Medicine|July 29, 2021
Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trialRaquel Laza-Briviesca, Alberto Cruz-Bermúdez, Ernest Nadal, et al.
Pageof 11